Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3

被引:22
作者
Guseva, NV
Taghiyev, AF
Rokhlin, OW
Cohen, MB
机构
[1] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA
关键词
CD95; cell death; prostatic neoplasms; Bcl-2;
D O I
10.1002/pros.10095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Two main pathways of apoptosis in mammalian cells have been described: the death receptor pathway and the mitochondrial pathway. Two different cell types have been identified for Fas-mediated apoptosis, each using almost exclusively one of two different signaling pathways. Human prostatic carcinoma cell line, PC3 is sensitive to Fas-mediated apoptosis, but relation of receptor and mitochondrial pathways is not clear. Methods. Cell viability was estimated by calcein assay. Apoptosis was determined by preparation of DNA ladder. Expression of Fas-associated death domain-dominant negative (FADD-DN) and Bcl-2, activation of caspases, PARP, DFF45, Bid cleavage, and cytochrome c release were assessed using Western blotting techniques. [S-35] Methionine-labeled caspase-3 was transcribed in vitro and translated using the TNT kit (Promega). A vector containing caspase-3 was prepared by the ligation of EcoR I/BamHI flanked PCR fragment of full size caspase-3 cDNA into pBlusckript II SK(+/-) (Stratagen). Results. Overexpression of both FADD-DN and Bcl-2 genes prevent Fas-mediated apoptosis in PC3. As predicted, overexpression of FADD-DN prevented activation of caspase-8 and Bid cleavage and attenuated the release of cytochrome c and activation of caspases -2, -7, and -9. Bcl-2 overexpression did not affect caspase-8 activation and cleavage of Bid but blocked the release of cytochrome c and activation of mitochondria localized caspases -2, -7, and -9. Overexpression of FADD-DN and Bcl-2 affected the activation of caspase-3 and PARP cleavage differently: FADD-DN attenuated the activation of caspase-3 and PARP cleavage whereas Bcl-2 overexpression prevented caspase-3 activation and completely blocked cleavage of PARP. Conclusions. These data suggest that activation of caspase-8 is necessary but not sufficient to complete Fas-mediated apoptosis in PC3 cells without activation of the mitochondrial pathway. In addition, caspase-3 activation after Fas-receptor ligation involves two steps and is dependent on mitochondrial activation.
引用
收藏
页码:231 / 240
页数:10
相关论文
共 37 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[3]  
Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961
[4]   The levels of MDM2 protein are decreased by a proteasome-mediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages [J].
Cho, JW ;
Park, JC ;
Lee, JC ;
Kwon, TK ;
Park, JW ;
Baek, WK ;
Suh, SI ;
Suh, MH .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (02) :135-139
[5]  
Eguchi Y, 1999, CANCER RES, V59, P2174
[6]   Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis [J].
Fulda, S ;
Meyer, E ;
Friesen, C ;
Susin, SA ;
Kroemer, G ;
Debatin, KM .
ONCOGENE, 2001, 20 (09) :1063-1075
[7]  
Gastman BR, 2000, CANCER RES, V60, P6811
[8]  
Gewies A, 2000, CANCER RES, V60, P2163
[9]   Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death [J].
Gross, A ;
Yin, XM ;
Wang, K ;
Wei, MC ;
Jockel, J ;
Millman, C ;
Erdjument-Bromage, H ;
Tempst, P ;
Korsmeyer, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1156-1163
[10]   Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis [J].
Hu, YM ;
Benedict, MA ;
Ding, LY ;
Núñez, G .
EMBO JOURNAL, 1999, 18 (13) :3586-3595